Speaker Bio
Marvin Däumichen is a co-founder of the MIND Foundation and serves as the Head of Collaboration Programs in the MIND Executive Board. During the initial phase of MIND, Marvin coordinated the Science Committee and has since overseen the organization’s research collaborations and science communications, and developed several of the MIND programs such as a global journal club network (uniMIND) and the multilingual, interdisciplinary MIND Blog.
His academic background lies in the cultural and social sciences. Marvin holds a Master of Arts in American Studies from the Humboldt University of Berlin, which he earned in 2018 after completing a B.Ed. in Linguistics and Education. He has recently completed a a Ph.D. in sociology of psychoactive substances and digital media.
Marvin’s research focuses on socialization within the context of digital media and psychoactive substances and the development of a mature societal implementation of altered states of consciousness.
ICPR 2024 Abstract
Navigating Acceptance: Unveiling attitudes and the impact of balanced communication on psychedelic-assisted therapy implementation
Navigating Acceptance: Unveiling attitudes and the impact of balanced communication on psychedelic-assisted therapy implementation
This study explored acceptance, knowledge, and attitudes surrounding the implementation of psychedelic therapies (PAT) into the mental health care system, particularly in German-speaking countries. With growing interest in the therapeutic potential of psychedelics, understanding mediators of acceptance towards PAT is crucial to support positive societal integration. We conducted a mixed-methods investigation applying quantitative methods in a survey (n=1456) as well as eleven qualitative focus group interviews to comprehensively address attitudes, knowledge, and themes among medical doctors, psychotherapists, patients, and the public.
Results revealed generally positive attitudes, with a notable desire for further research and education. However, concerns about safety and accessibility were identified, underscoring the need for careful implementation. Themes emerged around perceived therapeutic factors and concerns associated with psychedelic therapy. Noteworthy findings included the significance of the therapeutic relationship, self-efficacy, spiritual experiences, emotional processing, and neuroplasticity as potential therapeutic factors. Concerns encompassed issues of reductionism, commercialization, and challenges related to accessibility.
The study provided a comprehensive exploration of perspectives, offering valuable insights for future developments in this evolving field. Importantly, we found that balanced communication about risks and potentials of PAT predicts increased acceptance, which should be taken into account for all science and medical communications regarding PAT.
In sum, the findings highlight the delicate balance between potentials and risks required for the ethical and accessible integration of PAT into existing mental health frameworks. Policymakers, insurers, clinicians, and researchers must collaboratively address these concerns to foster a responsible and evidence-based approach to the implementation of PAT in mental health.